Results: A total of 4,452 ARDS survivors were included in this study, with 895 patients (20.1%) in the pre-ARDS insomnia disorder group and 536 (12.6%) patients in the post-ARDS insomnia disorder group. ARDS survivors who received a diagnosis of insomnia disorder before ARDS diagnosis were defined as the pre-ARDS insomnia disorder group, whereas those who had no history of insomnia disorder but received a new diagnosis of insomnia disorder within 1 year of diagnosis of ARDS were defined as the post-ARDS insomnia disorder group. We included adult patients (⩾18 years of age) admitted to intensive care units for ARDS treatment from January 1, 2010, to December 31, 2018, and who survived for ⩾1 year after diagnosis, defined as ARDS survivors. Methods: The National Health Insurance Database of South Korea was used for this nationwide cohort study. We also examined the association between insomnia and 2-year all-cause mortality. Objectives: This study aimed to investigate insomnia prevalence and its associated factors among ARDS survivors. However, insomnia prevalence, its associated factors, and its impact on long-term survival remain controversial. Poor sleep hygiene may include mobile phone or TV use while in bed, spending too long in bed.Ī sleep diary ( paper or watch which monitors sleep patterns) can assist in the assessment of insomnia, and help patients with to monitor and recognise their sleep habits.Rationale: As the most common type of sleep disorder, insomnia disorder can develop as a sequela among acute respiratory distress syndrome (ARDS) survivors.

DASS 21, K10, Oestrogen Deficiency Score, or bloods e.g. Sleep historyincludes sleep quantity (See night-time symptoms above) and daytime function (See daytime symptoms above), and sleep hygiene (relating to environmental factors, physiologic factors, behaviour and habits), onset and trajectory of insomnia symptoms, previous treatments used and effect of these treatments and checking for co-morbid conditions as well as excluding other potential causes of insomnia (mental health screening tools e.g. Causes clinically significant distress or impairment in social, occupational, educational, academic, behavioral, or other important areas of daytime functioning (See daytime symptoms below)Ī diagnosis of insomnia disorder is based upon patient-reported sleep history and the use of the Sleep Condition Indicator (SCI) or Insomnia Severity Index (ISI) questionnaires.Occurs despite adequate opportunity for sleep.Present for at least 3 nights per week for 3 months.The insomnia disorder’s difficulty falling and/or staying asleep including waking too early is: Early waking (termination of sleep >30 minutes before desired wake time) and unable to fall back to sleep.Difficulty maintaining sleep(wake periods >30 min) and unable to fall back to sleep.Difficulty initiating sleepdefined by sleep latency (time taken to fall asleep >30 min).Insomnia disorder is characterised by self-reported ‘Difficulties Initiating and/or Maintaining Sleep’ (DIMS).

At least 30% of the general population report symptoms of sleep disturbance, while 10-15% report symptoms indicative of chronic insomnia disorder. Cognitive Behavioural Therapy for Insomnia (CBTi)Ĭhronic insomnia or insomnia disorder negatively impacts mental and physical health and leads to increased healthcare costs.Brief Behavioural Therapy for Insomnia (BBTi).Basic Sleep and Sleep Hygiene Education.Pathogenesis, Risk Factors & Development.Insomnia - Steps in Assessment & Management.Treatment Options - Positional Therapy (PT).Treatment Options - Mandibular Advancement Splint (MAS).

Treatment Options - Continuous Positive Airway Pressure (CPAP).

Acute insomnia death